S. Harland

发表

The pT1 G3 bladder tumour.

B. Birch, S. Harland, 1989, British journal of urology.

Parental Employment at Time of Conception and Risk of Cancer in Offspring

C. Tyrrell, R. Henderson, S. Harland, 1991 .

The comparative values of bone marrow aspirate and trephine for obtaining bone scan-targeted metastases from hormone-refractory prostate cancer

J. Masters, H. Payne, P. Ell, 2002, Prostate Cancer and Prostatic Diseases.

The role of the histopathologist in the management of testicular germ cell tumour in adults

M. C. Parkinson, A. Sandison, P. Harnden, 2001, Histopathology.

Amplification of the androgen receptor gene in bone metastases from hormone‐refractory prostate cancer

J. Bartlett, J. Masters, J. Edwards, 2002, The Journal of pathology.

Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: defining a high risk group.

S. Fosså, A. Horwich, G. Mead, 1998, The Journal of urology.

The familial influence on bilateral testicular germ cell cancer: Medical Research Council study TER2.

A. Horwich, G. Mead, G. Daugaard, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy.

S. Fosså, A. Horwich, S. Kaye, 1997, European journal of cancer.

Risk factors for carcinoma in situ of the contralateral testis in patients with testicular cancer. An interim report.

S. Fosså, A. Horwich, S. Stenning, 1993, European urology.

GONADOTROPIN AND SEX-HORMONE LEVELS IN TESTIS CANCER-PATIENTS WITH AND WITHOUT CARCINOMA IN-SITU OF THE CONTRALATERAL TESTIS

S. Fosså, A. Horwich, S. Stenning, 1994 .

Epirubicin carboplatin and 5-fluorouracil (ECarboF) chemotherapy in metastatic hormone refractory prostate cancer

A. Birtle, S. Harland, J. Newby, 2004, British Journal of Cancer.

A phase II study of continuous infusion 5-fluorouracil (5-FU) with epirubicin and cisplatin in metastatic, hormone-resistant prostate cancer: an active new regimen.

S. Harland, D. Chao, M. von Schlippe, 1997, European journal of cancer.

First report of an isolated jejunal seminoma: presentation with melaena and iron deficiency anaemia.

H. Payne, R. Brown, S. Harland, 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

Inheritance and testicular cancer.

S. Harland, P. Nicholson, 1995, British Journal of Cancer.

Outcome in carcinoma in situ of bladder treated with intravesical bacille Calmette-Guérin.

M. Parkinson, S. Harland, C. Charig, 1992, British journal of urology.

Survival prospects after screen‐detection of prostate cancer

S. Harland, S. Harland, P. Nicholson, 2002, BJU international.

The management of superficial bladder cancer: an interactive seminar.

B. Ellis, J. Mcfarlane, S. Harland, 1996, British journal of urology.

Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report.

M. Williams, S. Fosså, A. Horwich, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study. MRC Advanced Bladder Cancer Working Party.

M. Parmar, P. Clark, G. Griffiths, 1998, British Journal of Cancer.

Do all patients with bilateral testis cancer have a hereditary predisposition?

S. Harland, E. Rapley, P. Nicholson, 2007, International journal of andrology.

Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis

C. Fowler, S. Harland, C. Fowler, 2001, British Journal of Cancer.

Evaluation of endothelial markers in detecting blood and lymphatic channel invasion in pT1 transitional carcinoma of bladder

M. C. Parkinson, P. Ramani, S. Harland, 1991, Histopathology.